Newsroom

Newsroom

NeoGenomics To Participate In The Stephens Annual Investment Conference 2021

Press Release
Read More

Quantifying perivascular immune cells in the stroma of human triple negative breast tumors using deep learning spatial analytics

Literature
Read More

Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle TICA™

Literature
Read More

A novel cross-site analysis of Vectra® Polaris™ multiplex fluorescence PD-1/PD-L1 immunohistochemistry on colorectal cancer with high and low microsatellite instability

Literature
Read More

NeoGenomics Appoints Dave Daly to Its Board of Directors

Press Release
Read More

NeoGenomics Announces Leadership Team Transition

Press Release
Read More

NeoGenomics Reports Revenue of $121 Million in the Third Quarter

Press Release
Read More

Talking Cancer: Conversations with Trailblazers, Advocates, Patients, and Medical Ambassadors

Blog
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients